Apotheek Devos
ActiveSummary
The annual accounts of Apotheek Devos for financial year 2025 show a net loss of 64% of the equity at the start of that year. The 2025 annual accounts show equity of €13,338 and a net result of -€24,132. Equity is shrinking by about 12% per year across the filed financial years. Its solvency ranks better than 13% of 4,978 sector peers (NACE 47, financial year 2025). The company has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.8% (low).
Directors
Owners and capital
Owners
1 ownerChain of control
- Pharma Invest Devos
- Apotheek Devos
Highest known parent: Pharma Invest Devos. The sources do not say who stands above it.
Owners 1
-
99%
Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.